| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 09/21/1999 | US5955308 cDNA clone HEAOD54 that encodes a human 7-transmembrane receptor |
| 09/21/1999 | US5955304 DivIB |
| 09/21/1999 | US5955300 Immunoglobulin fusion protein with amino acid replacements immunosuppressant against autoimmune diseases; useful in the therapeutic treament of melanomas and leukemias |
| 09/21/1999 | US5955299 For diagnosis and treatment of systemic lupus erythematosus; antisense agents |
| 09/21/1999 | US5955282 Human galactosyltransferases |
| 09/21/1999 | US5955100 Prodrugs their preparation and use as pharmaceuticals |
| 09/21/1999 | US5955080 Self-adjuvanting peptide vaccine delivery system and production thereof |
| 09/21/1999 | US5955079 Composition comprising high molecular weight primary carrier, secondary carrier comprising t-dependent antigen conjugated to primary carrier, having enhanced antibody response to both carriers |
| 09/21/1999 | US5955076 Immunoactive peptides and antibodies and their use in anti-allergy treatment |
| 09/21/1999 | CA2192975C Benzimidazolone derivatives |
| 09/16/1999 | WO1999046379A2 Human receptor proteins; related reagents and methods |
| 09/16/1999 | WO1999046367A2 Methods of diagnosis and triage using cell activation measures |
| 09/16/1999 | WO1999046289A1 31 human secreted proteins |
| 09/16/1999 | WO1999046272A1 Serine peptidase modulators |
| 09/16/1999 | WO1999046268A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
| 09/16/1999 | WO1999046248A1 1,2-diazepane derivatives as interleukin-1beta converting enzyme inhibitors |
| 09/16/1999 | WO1999046242A1 Cycloalkene derivatives, process for producing the same, and use |
| 09/16/1999 | WO1999046237A1 Modulators of protein tyrosine phosphatases |
| 09/16/1999 | WO1999045962A1 Transgenic non-human animals capable of producing heterologous antibodies |
| 09/16/1999 | WO1999045961A1 Tertiary structure of peanut allergen ara h 1 |
| 09/16/1999 | WO1999045960A1 Enhancement of intracellular delivery and tissue targeting of drugs and genes |
| 09/16/1999 | WO1999045959A1 Humanized antibody and uses thereof |
| 09/16/1999 | WO1999045958A1 Cd154 blockade therapy for modulation of immune responses to implanted devices |
| 09/16/1999 | WO1999045957A2 Combined vaccine compositions |
| 09/16/1999 | WO1999045955A1 DIAGNOSIS, PREVENTION AND TREATMENT OF ULCERATIVE COLITIS, AND CLINICAL SUBTYPES THEREOF, USING MICROBIAL UC pANCA ANTIGENS |
| 09/16/1999 | WO1999045954A1 Hla-binding peptides and their uses |
| 09/16/1999 | WO1999045928A1 IgE ANTIBODY PRODUCTION INHIBITORS AND AUTOIMMUNE DISEASES INHIBITORS |
| 09/16/1999 | WO1999045904A1 Delivery system to modulate immune response |
| 09/16/1999 | WO1999045788A1 Food products having enhanced cocoa polyphenol content and processes for producing same |
| 09/16/1999 | WO1999036091A3 Method for inhibiting cd95-independent apoptosis in aids |
| 09/16/1999 | WO1999033868A3 Human papillomavirus vaccine |
| 09/16/1999 | WO1999033355A3 Fat blend |
| 09/16/1999 | WO1999015657A3 53bp2 complexes |
| 09/16/1999 | CA2323787A1 Humanized antibody and uses thereof |
| 09/16/1999 | CA2323632A1 Hla-binding peptides and their uses |
| 09/16/1999 | CA2323493A1 Modulators of protein tyrosine phosphatases (ptpases) |
| 09/16/1999 | CA2323443A1 Ige antibody production inhibitors and autoimmune diseases inhibitors |
| 09/16/1999 | CA2323236A1 Human receptor proteins; related reagents and methods |
| 09/16/1999 | CA2323210A1 Enhancement of intracellular delivery and tissue targeting of drugs and genes |
| 09/16/1999 | CA2322728A1 31 human secreted proteins |
| 09/16/1999 | CA2322618A1 Methods of diagnosis and triage using cell activation measures |
| 09/16/1999 | CA2322472A1 Delivery system to modulate immune response |
| 09/15/1999 | EP0941738A1 Antigenic conjugates of conserved lipopolysaccharides of gram negative bacteria |
| 09/15/1999 | EP0941736A1 Oral immunity enhancing agent containing peptidoglycans |
| 09/15/1999 | EP0941333A1 Immunogenic detoxified mutant e. coli lt-a toxin |
| 09/15/1999 | EP0941329A1 Methods for preventing graft rejection in transplantation and for producing a universal gene therapy host cell using lymphocyte activation (lag-3) |
| 09/15/1999 | EP0941322A2 Bovine lactation associated immunotropic protein (cd14), encoding gene and application in b cell activation |
| 09/15/1999 | EP0941321A1 Circularly permuted polypeptides as novel stem cell factor receptor agonists |
| 09/15/1999 | EP0941316A1 Human p2x purinoreceptor |
| 09/15/1999 | EP0941241A1 $i(BORDETELLA) STRAIN EXPRESSING THE FHA HYBRID, LIPOSOMES AND VACCINES |
| 09/15/1999 | EP0941238A2 Mutant forms of fas ligand and uses thereof |
| 09/15/1999 | EP0941100A2 Pharmaceutical compositions containing lamivudine and zidovudine |
| 09/15/1999 | EP0941089A2 Compositions and methods for treating or preventing inflammatory diseases |
| 09/15/1999 | EP0941082A2 New use for 1,3-propanediol derivatives |
| 09/15/1999 | EP0941067A2 Stable glassy state powder formulations |
| 09/15/1999 | EP0799188B1 Amides of mono and dicarboxylic acids with glycosamines, selectively active on the cannabinoid peripheral receptor |
| 09/15/1999 | EP0741697B1 Amino acid derivatives and their use as phospholipase a2 inhibitors |
| 09/15/1999 | EP0611304B1 Use of acetylated mannan (acemannan) for the regulation of blood cholesterol levels and for removing plaques in blood vessels |
| 09/15/1999 | CN1228780A Phosphinic acid amides as matrix metalloprotease inhibitors |
| 09/15/1999 | CN1228779A Spirocyclic metalloprotease inhibitors |
| 09/15/1999 | CN1228777A Pyridyl alkene- and pyridyl alkine-acid amides as cytostatics and immunosuppressives |
| 09/15/1999 | CN1228773A Heterocyclic metalloprotease inhibitors |
| 09/15/1999 | CN1228712A Aqueous-based pharmaceutical composition |
| 09/15/1999 | CN1228705A Use of oligosaccharide as immunomodulator in dermato-cosmetic composition |
| 09/15/1999 | CN1228697A Method for in vivo reduction of iron levels and compositions useful therefor |
| 09/15/1999 | CN1228696A Use of PKC inhibitors for manufacture of medicament for treatment of AIDS |
| 09/15/1999 | CN1045088C Purine and guanine compounds as inhibitors of PNP |
| 09/14/1999 | US5952510 1,3-dihydro-1-(phenylalkenyl)-2H-imidazol-2-one derivatives having PDE IV and cytokine inhibiting activity |
| 09/14/1999 | US5952499 Therapeutic compound-fatty acid conjugates |
| 09/14/1999 | US5952483 Human IκB-β |
| 09/14/1999 | US5952382 Inhibiting the biological effects of an overregulation of retinoid acid receptors and/or of a hypervitaminosis a; treating skin disorder, eye vision defects, skin aging |
| 09/14/1999 | US5952373 Applying to the skin an effective amount of one or more flavonoids |
| 09/14/1999 | US5952368 5-aroylpyrrol-2-ylmethylarene derivatives |
| 09/14/1999 | US5952313 Composition for antagonizing gram negative bacterial endotoxic activity, comprising a pharmaceutically acceptable carrier and an antagonizing amount of a lipopolysaccharide from a rhizobium etli; treatment of septic shock or toxic shock |
| 09/14/1999 | US5952302 Human therapeutic uses of BPI protein products |
| 09/14/1999 | US5952296 Method of using relaxin as therapeutic or preventing agent |
| 09/14/1999 | US5952232 Expandible microparticle intracellular delivery system |
| 09/14/1999 | US5952228 Isolated cytolytic T cells which are specific for complexes OF HLA- B35 molecules and the peptide PHE Pro Ser Asp Ser Trp Cys Tyr PHE, and uses thereof |
| 09/14/1999 | US5952220 Preparing a dilute viral suspension in an aqueous solution which is then nebulised with gas pressure or ultrasound; treatment of respiratory diseases, asthma, lung cancer, cystic fibrosis |
| 09/14/1999 | US5952214 Human growth-related CDC10 homolog |
| 09/14/1999 | US5952181 Hybridizing polynucleotide sequence to complementary polynucleotide forming a complex, detecting complex formation; anticarcinogenic agent, treatment of psychological disorders, alzheimer's disease |
| 09/14/1999 | US5952175 DNA encoding a human progesterone receptor complex p23-like protein |
| 09/14/1999 | US5952001 Preparing pharmaceutical, dermatological or cosmetic preparations for the prevention or treatment of allergic manifestations such as skin allergy, bronchial asthma, or inflammation, or as free radical scavengers |
| 09/14/1999 | US5951988 Comprising a quaternary ammonium salt in a compatible solvent e.g. a lower alkanol, emulsifier, an oil and buffer; vaccine; viruses; veterinary medicine |
| 09/14/1999 | US5951984 Administering immunogen selected from group of protein and peptide to mammel, wherein mammel does not ingest a fat-soluble component substance within 4 hours before and within 2 hours after ingestion of the immunogen |
| 09/14/1999 | US5951983 A light chain framework region derived from a human antibody, a heavy chain framework region derived from a human antibody and light chain cdrs of the non-human monoclonal antibody produced by the cell line deposited as atcc hb11423; |
| 09/14/1999 | US5951982 Administering an antibody thaat binds an epitope of vcd44; antitumor,-metastasis and carciogenic agents |
| 09/14/1999 | US5951976 Vaccinating a mammal by administering a composition comprising an opsonin-enhanced cell comprising said selected antigen with the provision the opsonin does not bind to a receptor for a fragment of c33 |
| 09/14/1999 | US5951971 Eye-drops for treatment of eye disorders and surrounding area comprising cyclosporin and surfactant selected from polyoxyethylene fatty acid esters, polyoxyethylene alkylphenol ether and polyoxyethylene alkyl ethers |
| 09/14/1999 | CA2150483C Pyrazoles and pyrazolopyrimidines |
| 09/12/1999 | CA2265209A1 Method of preventing allograft rejection |
| 09/10/1999 | WO1999045102A1 Method for activating natural killer (nk) cells |
| 09/10/1999 | WO1999045098A2 Delivery or proteins into eukaryotic cells with recombinant yersinia |
| 09/10/1999 | WO1999045031A2 Cd147 binding molecules as therapeutics |
| 09/10/1999 | WO1999045024A1 Cholenic acid amides and pharmaceutical compositions thereof |
| 09/10/1999 | WO1999045015A1 5-imino-13-deoxy anthracycline derivatives, their uses, and processes for preparing them |
| 09/10/1999 | WO1999045009A1 Heterocyclo-substituted imidazopyrazine protein tyrosine kinase inhibitors |
| 09/10/1999 | WO1999044995A1 Novel pyridazine derivatives and drugs containing the same as the active ingredient |
| 09/10/1999 | WO1999044636A2 Il-12 enhancement of immune responses to t-independent antigens |
| 09/10/1999 | WO1999044635A1 Enhancement of immunity by intranasal inoculation of il-12 |